The study found that GLP-1 medications, in particular, showed significant weight regain after treatment discontinuation.

LinkGevity is among a cluster of biotech firms in Cambridge working on potential longevity treatments. They include clock.bio ...

"My scene was supposed to be funny, and it got nothing in the f---ing Chinese Theatre," the comedian says while discussing ...

When glucagon-like peptide-1 receptor agonists (GLP-1s) like semaglutide (Wegovy) and liraglutide (Saxenda) were approved for ...

In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...

Researchers in a recent study discovered that people taking medications to help them lose weight might experience weight gain ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

Editors: Story has been updated from original, with material from the president of the Arizona Obesity Organization. Slug: ...

The diabetes drugs Ozempic and Wegovy have been linked to an increased risk of sudden vision loss and blindness due to a rare ...

A spokesperson said: “Results from the STEP trials demonstrate that weight regain is likely once medication is stopped.

More than 80 U.S. lawmakers asked the FDA to stop counterfeit GLP-1 drugs linked to Chinese suppliers from entering the ...

Those projections of reduced spending were reflected in a survey released in December by data analytics firm Numerator that ...